Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study

Published:2022-08-13 Issue:4 Volume:9 Page:649-657
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Uchiyama Kiyotaka^ORCID,Kojima Daiki,Hama Eriko Yoshida,Nagasaka Tomoki,Nakayama Takashin,Takahashi Rina,Tajima Takaya,Morimoto Kohkichi,Washida Naoki,Itoh Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-022-00325-3.pdf

Reference33 articles.

1. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group, et al. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure - Digest Version. Circ J. 2019;83:2084–184.

2. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, et al. Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319–31.

3. Inomata T, Ikeda Y, Kida K, Shibagaki Y, Sato N, Kumagai Y, Kanagawa Aquaresis Investigators, et al. Effects of additive tolvaptan vs increased furosemide on heart failure with diuretic resistance and renal impairment: results from the K-STAR study. Circ J. 2017;82:159–67.

4. Otsuka T, Sakai Y, Ohno D, Murasawa T, Sato N, Tsuruoka S. The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure. Clin Exp Nephrol. 2013;17:834–8.

5. Katsumata M, Hirawa N, Sumida K, Kagimoto M, Ehara Y, Okuyama Y, et al. Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure. Clin Exp Nephrol. 2017;21:858–65.